Jeremy VisserApr 31 minVIDEO: Lutikizumab effective in HS patients, new study showsLutikizumab 300 mg was shown to be more effective than placebo in HS patients.
Allan RyanApr 12 minRacial bias persists in dermatologic diagnosis despite input from AIA new study from Northwestern University in Chicago has identified a concerning trend in the accuracy of skin disease diagnosis across...
Jeremy VisserMar 271 minVIDEO: Study shows apremilast effective for moderate-to-severe plaque PsO in pediatric patientsApremilast is effective for the treatment of moderate-to-severe plaque psoriasis short-term in pediatric patients.
Allan RyanMar 252 minInaugural Dr. Mercy Alexis Research Grant awarded to Vancouver dermatologistDr. Tashmeeta Ahad has been awarded the first Dr. Mercy Alexis Research Grant in Skin of Color Dermatology for her project on...
John EvansMar 222 minViral conditions to consider for morbilliform eruptions in pediatric patientsMorbilliform eruptions of viral exanthems are common in the pediatric in-patient setting, and several possible diagnoses can be suspected...
Jeremy VisserMar 211 minVIDEO: Blood monocyte count in PsO patients may predict early response to secukinumabPlaque psoriasis patients with lower blood monocyte counts at baseline achieved early response when treated with secukinumab.